That is true, however the motivation to actually p

That is true, however the motivation to actually push the oncology really started to move forward with Pestell. I’m not a fan of Pestell at all, how could a dr have the road paved in front of him to do his life’s work and not take it? However the optics of a top dr being in charge was a big move. Keep in mind, there have always been suggestions of other indications but they were not moving forward with much strength because of funding. The one that really bothers me is GvHD, this was a cheap and quick indication that could be on the market now if it had not been shelved so many times. It is the perfect base hit to get things rolling and not starting the trial to me has been a huge mgmt mistake.